CDA and neoplasm: Most interestingly, following anti-PD-1 therapy, the survival rate of KPC FC1245 tumor–bearing mice was markedly increased by genetic suppression of CDA, confirming the theory that CDA targeting overcomes anti-PD-1 resistance.